Journal of Clinical Immunology

, Volume 25, Issue 2, pp 127–133 | Cite as

Determinants of CD4 Counts Among HIV-Negative Ethiopians: Role of Body Mass Index, Gender, Cigarette Smoking, Khat (Catha Edulis) Chewing, and Possibly Altitude?

  • C. Abuye
  • A. Tsegaye
  • C. E. West
  • P. Versloot
  • E. J. Sanders
  • D. Wolday
  • D. Hamann
  • T. F. Rinke De Wit
  • A. L. Fontanet


To study the determinants of CD4% and CD4 counts among HIV-negative Ethiopians, and to identify factors susceptible to explain the low CD4 counts observed among Ethiopian subjects. Cohort studies among factory workers in Akaki and Wonji, Ethiopia. Clinical and laboratory examinations, including determination of HIV serological status and T-cell subsets, were performed during follow-up visits every six months. In addition, micronutrients (retinol, carotenoids, tocopherol, transferrin receptor, and selenium) plasma concentrations were determined in a subset of 38 HIV-positive and 121 HIV-negative participants. HIV-negative participants with at least one CD4 count measurement were 157 females in Akaki, 203 males in Akaki, and 712 males in Wonji. CD4 counts were independently and positively associated with body mass index (through an increase in lymphocyte counts), female gender (through an increase in CD4%), cigarette smoking (through an increase in CD4%), khat chewing (through an increase in both lymphocyte counts and CD4%), and Akaki study site (through a large increase in lymphocyte counts compensating a decrease in CD4%). Intestinal parasitic infections were not associated with CD4% or CD4 counts. Retinol, carotenoids, and α-tocopherol plasma concentrations decreased with HIV infection and advancing immunosuppression, but were not associated with CD4 counts among HIV-negative subjects. Low body mass index among Ethiopians may have contributed to their overall low CD4 counts. Other factors remain to be elucidated.


CD4 counts micronutrients BMI altitude Ethiopia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Levy JA: HIV pathogenesis and long-term survival. AIDS 7:1401–1410, 1993Google Scholar
  2. 2.
    Tollerud DJ, Clark JW, Brown LM, Neuland CY, Pankiw-Trost LK, Blattner WA, Hoover RN: The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers. J Clin Immunol 9:214–221, 1989Google Scholar
  3. 3.
    Maini MK, Gilson RJ, Chavda N, Gill S, Fakoya A, Ross EJ, Phillips AN, Weller IV: Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med 72:27–31, 1996Google Scholar
  4. 4.
    Kam KM, Leung WL, Kwok MY, Hung MY, Lee SS, Mak WP: Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults. Clin Diagn Lab Immunol 3:326–330, 1996Google Scholar
  5. 5.
    Levin A, Brubaker G, Shao JS, Kumby D, O’Brien TR, Goedert JJ, Strauss KW, Blattner WA, Hannet I: Determination of T-lymphocyte subsets on site in rural Tanzania: Results in HIV-1 infected and non-infected individuals. Int J STD AIDS 7:288–291, 1996Google Scholar
  6. 6.
    Tugume SB, Piwowar EM, Lutalo T, Mugyenyi PN, Grant RM, Mangeni FW, Pattishall K, Katongole-Mbidde E: Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol 2:233–235, 1995Google Scholar
  7. 7.
    Zekeng L, Sadjo A, Meli J, Kaptue L, Mpoudi Ngole E, Hess G, Babiel R: T-lymphocyte subset values among healthy Cameroonians. J Acquir Immune Defic Syndr Hum Retrovirol 14:82–83, 1997Google Scholar
  8. 8.
    Vithayasai V, Sirisanthanna T, Sakonwasun C, Suvanpiyasiri C: Flow cytometric analysis of T-lymphocytes subsets in adult Thais. Asian Pac J Allergy Immunol 15:141–146, 1997Google Scholar
  9. 9.
    Shahabuddin S: Quantitative differences in CD8+ lymphocytes, CD4/CD8 ratio, NK-cells, and HLA-DR+ activated T cells of racially different male populations. Clin Immunol Immunopathol 75:168–170, 1995Google Scholar
  10. 10.
    Lee BW, Yap HK, Chew FT, Quah TC, Prabhakaran K, Chan GS, Wong SC, Seah CC: Age and sex related changes in lymphocyte subpopulations of healthy Asian subjects: From birth to adulthood. Cytometry 26:8–15, 1996Google Scholar
  11. 11.
    Pollack S, Fuad B, Etzioni A: CD4 T-lymphocytopenia without opportunistic infections in HIV-seronegative Ethiopian immigrants to Israel. Lancet 342(8862):50–51, 1993Google Scholar
  12. 12.
    Worku S, Christensson A, Bjorkman A, Islam D: Higher proportions of CD8+ T-cells in the blood in healthy adults from Ethiopia and Bangladesh compared to Sweden. Trans R Soc Trop Med Hyg 91:618–622, 1997Google Scholar
  13. 13.
    Tsegaye A, Messele T, Tilahun T, Hailu E, Sahlu T, Doorly R, Fontanet AL, Rinke de Wit TF: Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 6:410–414, 1999Google Scholar
  14. 14.
    Messele T, Abdulkadir M, Fontanet Al, Petros B, Hamann D, Koot M, Roos MT, Schellekens PT, Miedema F, Rinke de Wit TF: Reduced naive and increased activated CD4 and CDS cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol 115:443–450, 1999Google Scholar
  15. 15.
    Kassu A, Tsegaye A, Petros B, Wolday D, Hailu E, Tilahun T, Hailu B, Roos MT, Fontanet AL, Hamann D, De Wit TF: Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin Diagn Lab Immunol 8:1171–1176, 2001Google Scholar
  16. 16.
    Central Statistical Authority [Ethiopia] and ORC Macro: Ethiopia Demographic and Health Survey 2000. Addis Ababa, Ethiopia and Calverton, Maryland, USA: Central Statistical Authority and ORC Macro, 2001Google Scholar
  17. 17.
    Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile D, Antelman G, Mbise R, Herrera G, Kapiga S, Willett W, Hunter DJ: Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1 infected women in Tanzania. Lancet 351:1477–1482, 1998Google Scholar
  18. 18.
    Sahlu T, Fontanet A, Rinke de Wit T, Messele T, Doorly R, Yeneneh H, Bindels P, Coutinho R: Identification of a site for a cohort study on natural history of HIV infection in Ethiopia. J Acquir Immune Defic Syndr Hum Retrovirol 17:149–155, 1998Google Scholar
  19. 19.
    Kassa E, Rinke de Wit TF, Hailu E, Girma M, Messele T, Mariam HG, Yohannes S, Jurriaans S, Yeneneh H, Coutinho RA, Fontanet AL: Evaluation of the World Health Organisation staging system for HIV infection and disease in Ethiopia: Association between clinical stages and laboratory markers. AIDS 13:381–389, 1999Google Scholar
  20. 20.
    Chandra RK: Nutrition and immunology: From the clinic to cellular biology and back again. Proc Nutr Soc 58:681–683, 1999Google Scholar
  21. 21.
    Olmedilla B, Granado F, Gil-Martinez E, Blanco I, Rojas-Hidalgo E: Reference values for retinal, tocopherol, and main carotenoids in serum of control and insulin-dependent diabetic Spanish subjects. Clin Chem 43:1066–1071, 1997Google Scholar
  22. 22.
    Hazenberg MD, Otto SA, Cohen Stuart JW, Verschuren MC, Borleffs JC, Boucher CA, Coutinho RA, Lange JM, Rinke de Wit TF, Tsegaye A, van Dongen JJ, Hamann D, de Boer RJ, Miedema F: Increased cell division but not thymic dysfunction rapidly affects the TREC content of the naive T cell population in HIV-1 infection. Nat Med 6:1036–1042, 2000Google Scholar
  23. 23.
    Paglieroni TG, Holland PV: Circannual variation in lymphocyte subsets, revisited. Transfusion 34:512–624, 1994Google Scholar
  24. 24.
    Falkenbach A, Sedlmeyer A: Travel to sunny countries is associated with changes in immunological parameters. Photodermatol Photoimmunol Photomed 13:139–142, 1997Google Scholar
  25. 25.
    Pantelis C, Hindler CG, Taylor JC: Use and abuse of khat (Catha edulis): A review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychological Medicine 19:657–668, 1989Google Scholar
  26. 26.
    Connor TJ: Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): A stressor on the immune system. Immunology 111:357–367, 2004Google Scholar
  27. 27.
    House RV, Thomas PT, Bhargava HN: Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol 16:1–21, 1994Google Scholar
  28. 28.
    Kovacs JA, Vogel S, Albert JM, Falloon J, Davey RT Jr, Walker RE, Polis MA, Spooner K, Metcalf JA, Baseler M, Fyfe G, Lane HC: Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 335:1350–1356, 1996Google Scholar
  29. 29.
    Smith KA: Interleukin-2: Inception, impact, and implications. Science 240:1169–1176, 1998Google Scholar
  30. 30.
    Foussat A, Bouchet-Delbos L, Couderc J, Berrebi D, German-Fattal M, Maillot MC, Durand-Gasselin I, Galanaud P, Di Santo JP, Emilie D: Effects of exogenous IL-2 administration on the homeostasis of CD4+ T lymphocytes. J Clin Immunol 24:503–514, 2004Google Scholar
  31. 31.
    Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, Margolick JB, Phair JP, Mellors JW: Natural history of human immunodeficiency virus type 1 viremia after seroconversion and progression to AIDS in a large cohort of homosexual men. J Infect Dis 181:872–880, 2000Google Scholar
  32. 32.
    Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A: Do gender differences in CD4 cell counts matter? AIDS 13:2361–2364, 1999Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • C. Abuye
    • 1
  • A. Tsegaye
    • 2
  • C. E. West
    • 3
  • P. Versloot
    • 3
  • E. J. Sanders
    • 2
  • D. Wolday
    • 2
  • D. Hamann
    • 4
  • T. F. Rinke De Wit
    • 2
  • A. L. Fontanet
    • 5
    • 6
    • 7
  1. 1.Department of NutritionEthiopian Health and Nutrition Research Institute (EHNRI)Addis AbabaEthiopia
  2. 2.Ethio–Netherlands AIDS Research Project (ENARP)EHNRINetherlands
  3. 3.Division of Human Nutrition and EpidemiologyWageningen UniversityThe Netherlands
  4. 4.Department of Clinical Viro-Immunology. CLB and the Laboratory of Experimental and Clinical Immunology, Academic Medical CentreUniversity of AmsterdamThe Netherlands
  5. 5.Division of Public Health and EnvironmentMunicipal Health Service
  6. 6.Emerging Diseases Epidemiology UnitPasteur InstituteParisFrance
  7. 7.Emerging Diseases Epidemiology UnitPasteur InstituteParisFrance

Personalised recommendations